ISSN: 1342-1751
Journal Home
Journal Guideline
Clinical and Experimental Nephrology Q2 Unclaimed
Clinical and Experimental Nephrology is a journal indexed in SJR in Physiology and Physiology (medical) with an H index of 59. It has a price of 2690 €. It has an SJR impact factor of 0,656 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,656.
Clinical and Experimental Nephrology focuses its scope in these topics and keywords: basement, artery, kidney, serine, membrane, glomerular, nephropathypatient, nephrotic, medial, malariapathologic, ...
Type: Journal
Type of Copyright:
Languages: English
Open Access Policy: Open Choice
Type of publications:
Publication frecuency: -
2690 €
Inmediate OANPD
Embargoed OA0 €
Non OAMetrics
0,656
SJR Impact factor59
H Index146
Total Docs (Last Year)490
Total Docs (3 years)3844
Total Refs1056
Total Cites (3 years)431
Citable Docs (3 years)1.95
Cites/Doc (2 years)26.33
Ref/DocOther journals with similar parameters
Journal of Biological Rhythms Q2
Current Opinion in Physiology Q2
Nitric Oxide - Biology and Chemistry Q2
Redox Report Q2
Muscle and Nerve Q2
Compare this journals
Aims and Scope
Best articles by citations
Reduction by tranexamic acid of glomerular hypertrophy and increased glomerular expression of extracellular matrix components induced by streptozotocin diabetes in rats
View moreSafety and efficacy of a biliary-excreted angiotensin converting enzyme (ACE) inhibitor, temocapril, in combination with amlodipine in advanced diabetic nephropathy
View moreThe effectiveness of steroid therapy for patients with advanced IgA nephropathy and impaired renal function
View moreInhibition of gluconeogenesis and p -aminohipuric acid accumulation in rat renal cortical slices by ionic and nonionic contrast media
View moreClinical course of bucillamine-induced nephropathy in patients with rheumatoid arthritis
View moreA non-inferiority study of the novel selective urate reabsorption inhibitor dotinurad versus febuxostat in hyperuricemic patients with or without gout
View moreEosinophiluria from intra-articular hyaluronic acid injection
View moreDeterminants of prescribed dialysis dose and survival in a cohort of chronic hemodialysis patients
View moreCarbonic adsorbent AST-120 retards progression of renal failure by additive effect with ACEI and protein restriction diet
View moreRole of mitogen-activated protein kinase in the regulation of transforming growth factor-?-induced fibronectin accumulation in cultured renal interstitial fibroblasts
View moreEffect of ureteral obstruction on matrix metalloproteinase-2 in rat renal cortex
View moreInterleukin-33/ST2 signaling contributes to the severity of hemolytic uremic syndrome induced by enterohemorrhagic Escherichia coli
View moreTreatment of type 2 diabetic patients with kidney disease with AT 1 -receptor antagonists: lessons from recent trials
View moreA simple quantitative approach to analyzing the generation of the dysnatremias
View moreSuppression of experimental crescentic glomerulonephritis by peroxisome proliferator-activated receptor (PPAR)? activators
View moreExpression of MMP-9 in mesangial cells and its changes in anti-GBM glomerulonephritis in WKY rats
View moreDotinurad versus benzbromarone in Japanese hyperuricemic patient with or without gout: a randomized, double-blind, parallel-group, phase 3 study
View morePlatelet-derived growth factor stimulates matrix metalloproteinase-2 secretion in cultured human mesangial cells
View moreLetter to the editor
View moreAcute posterior leukoencephalopathy in a patient with nephrotic syndrome
View moreA clinical pharmacology study of the novel, selective urate reabsorption inhibitor dotinurad in outpatients
View moreMultimeric vitronectin in ascites is involved in fibroblast spreading of EPS in patients on CAPD therapy
View moreRoles of bone marrow cells in glomerular diseases
View moreEpithelial sodium channels expressed in Xenopus oocytes are activated by cyclic-AMP
View more
Comments